Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    24211163 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting
Has Results
Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-resistant Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: Placebo;   Drug: Dasatinib;   Drug: Docetaxel;   Drug: Prednisone

Indicates status has not been verified in more than two years